Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
International Journal of Cardiology|April 30, 2019
Same-day CIED implantation and discharge: Is it possible? The E-MOTION trial (Early MObilization after pacemaker implantaTION)Carlo Budano, Paolo Garrone, Davide Castagno, et al.Stroke|June 11, 2015
Selective Vulnerability of Cortical Border Zone to Microembolic InfarctMauro Bergui, Davide Castagno, Federico D'Agata, et al.Journal of Interventional Cardiology|August 14, 2012
Use and misuse of multivariable approaches in interventional cardiology studies on drug-eluting stents: a systematic reviewFabrizio D'Ascenzo, Erika Cavallero, Giuseppe Biondi-Zoccai, et al.American Heart Journal|November 19, 2011
Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysisDavide Castagno, Jonathan Baird-Gunning, Pardeep S Jhund, et al.Clinical Endocrinology|October 13, 2017
Hyperthyroidism in patients with ischaemic heart disease after iodine load induced by coronary angiography: Long-term follow-up and influence of baseline thyroid functional statusNadia Bonelli, Ruth Rossetto, Davide Castagno, et al.Journal of Cardiovascular Electrophysiology|November 13, 2012
Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic functionMatteo Anselmino, Stefano Grossi, Marco Scaglione, et al.Heart Rhythm|February 25, 2014
Long-term progression from paroxysmal to permanent atrial fibrillation following transcatheter ablation in a large single-center experienceMarco Scaglione, Cristina Gallo, Alberto Battaglia, et al.European Heart Journal. Cardiovascular Pharmacotherapy|December 20, 2021
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysisPietro Ameri, Vincenzo De Marzo, Giuseppe Biondi Zoccai, et al.Journal of the American College of Cardiology|May 12, 2012
Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) programDavide Castagno, Hicham Skali, Madoka Takeuchi, et al.European Journal of Clinical Investigation|July 26, 2024
Glucagon-like peptide-1 receptor agonist semaglutide reduces atrial fibrillation incidence: A systematic review and meta-analysisAndrea Saglietto, Giulio Falasconi, Diego Penela, et al.Pageof 8